Resolving the Gap: SPMs and PEA as the Missing Half of Your Inflammation Strategy

18 Jun 2026
Level 4 - Moore Room
Nutraceuticals
Most practitioners manage inflammation. Few address its resolution — a separate, active physiological process that routinely fails in chronic disease. Specialised pro-resolving mediators (SPMs) and palmitoylethanolamide (PEA) are the key players in this overlooked biology. Both are produced endogenously; both become functionally deficient across common patient presentations including ageing, obesity, and chronic pain. The evidence base is compelling. The clinical opportunity is largely untapped.
Speakers
Nathan Rose
Nathan Rose, Head of Education - Integria Healthcare | MediHerb | Eagle Clinical, Australia

Hosted by:

Eagle Clinical
Eagle Clinical
Stand: F46